BG Medicine, Inc. (BGMD)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.13+0.01 (+10.20%)
At close: 1:07 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close0.12
Bid0.00 x
Ask0.00 x
Day's Range0.12 - 0.14
52wk Range0.11 - 0.18
1y Target EstN/A
Market Cap1.54M
P/E Ratio (ttm)-0.19
Avg Vol (3m)12,478
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • BG Medicine, Inc. Earnings Q3, 2015
    Capital Cube11 months ago

    BG Medicine, Inc. Earnings Q3, 2015

    Click here to see latest analysisBG Medicine, Inc. reports financial results for the quarter ended September 30, 2015.We analyze the earnings along side the following peers of BG Medicine, Inc. – Psychemedics Corporation, Alere Inc., Laboratory Corporation of America Holdings, Meridian Bioscience, Inc., Abbott Laboratories, Cerner Corporation, Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc. […] (Read more...) The post BG Medicine, Inc. Earnings Q3, 2015 appeared first on CapitalCube.

  • Thomson Reuters StreetEvents11 months ago

    Edited Transcript of BGMD earnings conference call or presentation 17-Nov-15 1:30pm GMT

    Q3 2015 BG Medicine Inc Earnings Call

  • Accesswirelast year

    BG Medicine Due Diligence Report: Quietly Making Headway - Broad Street Alerts

    NEW YORK, NY / ACCESSWIRE / November 5, 2015 / BG Medicine, Inc. (OTCQB: BGMD) the developer of the BGM Galectin-3 recently announced that trading in the Company's common stock will be suspended on NASDAQ ...